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ABSTRACT
Objective: To describe ambulatory care clinicians’ perspectives on 
the effect of electronic prescribing (e-prescribing) systems on patient 
safety outcomes.
Study Design: Mixed method study of clinicians and staff in 64 
practices using 1 of 6 e-prescribing technologies in 6 US states. 
Methods: We used clinician surveys (Web-based and paper) and 
focus groups to obtain clinicians’ perspectives on e-prescribing and 
patient safety. 
Results: Providers highly valued having medications prescribed by 
other providers on the medication list and the ability to access pa-
tients’ medication lists remotely. Providers thought that there will 
always be prescription or medication errors and that the implemen-
ta tion of e-prescribing software changes rather than eliminates 
prescription or medication errors. New errors related to the dosing or 
scheduling of a medication, accidentally prescribing the wrong drug, 
or duplicate prescriptions.
Conclusions: Lessons from the ambulatory care trenches must be 
considered as technology moves forward so that the hypothesized 
patient safety gains will be realized.
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According to the 2001 National Ambulatory Medical Care Survey, 61.9% of all outpatient offi ce visits re-sulted in a clinician prescribing at least 1 medication.1
During 2001, an estimated 1.3 billion medications were pre-
scribed during outpatient offi ce visits, with an estimated av-
erage of 2.4 prescriptions per medication-related offi ce visit.1
The Institute of Medicine report To Err is Human, Building 
a Safer Health System estimated that medication errors were 
responsible for more than 7000 deaths annually.2 Given that 
at least $887 million is spent on preventable adverse drug 
events among Medicare recipients in the ambulatory setting,3
systems to prevent medication errors in ambulatory settings 
are sorely needed.
Electronic prescribing (e-prescribing) systems hold 
promise to improve the safety, quality, and effi ciency of 
healthcare.4 While e-prescribing is the direct computer-to-
computer transmission of prescription information from 
physician offi ces to pharmacies, these systems also allow 
for patient safety features including clinical decision sup-
port and sharing of patient pharmacy data across multiple 
prescribers. Great strides have been made to address the 
regulatory and high-level operational issues required to per-
mit this form of prescribing. All 50 states and Washington DC 
have implemented regulations permitting this form of pre-
scribing.5 In 2009, about 18% of eligible prescriptions were 
prescribed electronically.5 While e-prescribing adoption is 
increasing in the United States, a greater understanding of 
the role of e-prescribing technology solutions in improving 
patient-centered pharmacy care is warranted.
This large 1-year study, conducted to evaluate proposed 
standards for new e-prescribing transactions, provided the 
opportunity to evaluate healthcare providers’ opinions about 
the role of e-prescribing applications in improving patient 
safety. This study summarizes qualitative and quantitative 
data collected via focus groups and surveys of 64 practices 
in 6 states who used 1 of 6 different e-prescribing software 
systems. No other study to date has been performed on this 
P R A C T I C A L  I M P L I C A T I O N S
Clinicians viewed the following aspects of electronic prescribing  
(e-prescribing) to be most beneficial for improving patient safety:
n	 e-Prescribing enabled remote access to medication lists.
n	 e-Prescribing allowed clinicians to see what other providers were 
prescribing for their patients.
n	 While e-prescribing eliminated handwriting errors in the prescribing 
process, clinicians feared a new generation of errors related to the 
technology.
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scale. Including multiple vendors in multiple practice set-
tings provided a unique opportunity to fully understand 
perceptions about patient safety with respect to e-pre-
scribing in primary care settings.
The purpose of this study is to describe ambulatory 
care clinicians’ perspectives on the effect of electronic 
prescribing systems on patient safety.
METHODS
Study Sample
The Brown University Institutional Review Board ap-
proved the study protocol. SureScripts, LLC, the nation’s 
largest e-prescribing network, identified states with the 
highest e-prescribing activity on their network in the fall 
of 2005. To provide geographic diversity while consider-
ing practical and logistical issues, we selected the 6 states 
with the highest volume of e-prescribing transactions to 
be targeted for inclusion in the study: Florida, Massachu-
setts, New Jersey, Nevada, Rhode Island, and Tennessee. 
Within these states, SureScripts, LLC, identified physician 
software vendors with substantial activity who agreed 
to participate in the study: OnCallData, InstantDX, LLC 
(Gaithersburg, Maryland) in Rhode Island; PocketScript, 
Zix Corporation (Dallas, Texas) in Massachusetts and 
New Jersey; Rcopia, DrFirst, Inc (Rockville, Maryland) 
in New Jersey; Care360, Medplus, Inc (Mason, Ohio) 
in New Jersey and Florida; eMPOWERx, GoldStandard 
Multimedia, Inc (Tampa, Florida) in Florida; and Touch-
works, AllScripts, LLC (Chicago, Illinois) in Nevada and 
Tennessee.
All physician software systems were required to as-
sist in recruitment of ambulatory care practices with a 
patient mix of at least 25% Medicare-eligible patients. 
We developed participation agreements (approved by 
the Brown Institutional Review Board) and provided 
recruitment packets and training of information in the 
recruitment packets for each company. The resulting 
practices represented a convenience sample, as compa-
nies approached practices with which they had positive 
relations and which had participated in research previ-
ously. Thus, we were unable to estimate participation 
rates among potentially eligible practices. The data for 
the current study were derived from clinician surveys and 
focus groups. All data were collected before any changes 
to the e-prescribing software were made to accommodate 
the e-prescribing standards.
Clinician Surveys
Clinicians (n = 157) completed surveys available via 
the Web (75%) or paper (25%) in advance of or during 
the site visit. The survey captured perceptions of the im-
pact of e-prescribing on efficiency, work flow, and qual-
ity, as well as clinician views on patient communication 
regarding medication issues (Appendix A). The survey 
included 2 questions regarding the impact of e-prescrib-
ing on patient safety and quality of care (see Figures 1 
and 2). We estimated the clinician responses to the drug-
alerting questions for each physician software system. 
Vendor-specific results are presented without identifying 
the name of the vendor. To provide context in which to 
evaluate differences in these proportions, we described 
the software in relation to frameworks on recommended 
best practices for e-prescribing software.6,7 Two trained 
interviewers who had received one-on-one instruction 
regarding the functionality of all of the software products 
independently evaluated each product in relation to the 
60 recommendations. They coded each recommendation 
as being fully implemented, partially implemented, not at 
all implemented, or not applicable. Summary proportions 
for each conceptual domain were estimated from the 60 
recommendations.
Focus Groups
Two highly trained research assistants held focus 
groups (with a meal provided) before hours, at lunch, 
or after hours at the discretion of each practice between 
April and August 2006. A total of 276 clinicians and staff 
members participated in 64 focus groups after provid-
ing written informed consent. A sign listing the main 
topics for discussion was placed on the table for par-
ticipants to view (Table 1). We used an open-ended 
approach to elicit information about the benefits and 
drawbacks of e-prescribing, as well as the features of-
ten embedded within the e-prescribing software. Par-
ticipants were encouraged to describe their experiences 
with e-prescribing software and to provide suggestions 
for improving e-prescribing. Probes included questions 
about what aspects of e-prescribing were valuable, what 
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participants found difficult, suggested improvements in 
office procedures and software functionality, and other 
potentially valuable resources. Research assistants also 
used facilitative (eg, “Can you tell me more about that?” 
or “Any other opinions?”) and clarifying (eg, “When you 
say…, what do you mean by that?”) probes. Participants 
spontaneously addressed patient safety issues in the 
context of these discussions. Focus groups were record-
ed using 2 digital recorders with Pressure Zone Micro-
phones. Once all digital recordings were transcribed, 
research assistants double-checked every transcript for 
potential errors.
Qualitative methods are useful for studying complex 
phenomena such as communication, thoughts, expecta-
tions, and meaning, and for investigating people’s ex-
periences.8-10 An extensive hierarchical coding structure 
was initially developed to handle the large volume of 
qualitative data (Appendix B). This initial structure was 
based on the focus group protocol and review of initial 
transcripts, and was revised during active coding. Fif-
teen different parent nodes were defined to code all of 
the qualitative data. For this article, we honed in on the 
analysis of 2 nodes: (1) impact on clinical practice and (2) 
software features, because many e-prescribing software 
packages had additional features that may influence pa-
tient safety. Coders were instructed to include any com-
ments regarding patient safety in a subnode specifically 
for this purpose. We also evaluated text coded under 
“quality of care,” as patient safety issues were sometimes 
referred to in the context of quality of care.
Coders were trained in coding definitions and over-
all coding structure. A code book defined all codes and 
their relationships. All quotes were derived from the fo-
cus groups and individual interviews. We did not include 
information on drug alerts as part of this analysis, as the 
extensive nature of the findings related to drug alerts 
warranted a separate analysis.11
Consistency in the coding across team members was 
ensured by extensive training, coding meetings, a com-
mon code book, and group exercises. We also had 2 
members of the coding team independently code ap-
proximately 20% of transcripts and compared reports to 
identify any areas of coding that were not consistently 
applied by coders and for which additional training was 
required. A qualitative data review of the double-coded 
transcripts revealed that passages coded by each coder 
commonly appeared twice, indicating effective coding 
among those transcripts by the research staff. Manage-
ment and analysis of the data were conducted with NVivo 




Overall, all software vendors fully implemented at least 
half of the best-practices recommendations (range of 63% 
Figure 1. Perceptions of the Impact of e-Prescribing on Patient Safety, Overall and by e-Prescribing Technology Solutiona
20% 40% 60% 80%
Much better Somewhat better No change Somewhat worse
OVERALL (n = 145)
Vendor A (n = 28)
Vendor B (n = 30)
Vendor C (n = 4)
Vendor D (n = 26)
Vendor E (n = 43)
Vendor F (n = 14)
0% 100%
aThe participant survey asked “How do electronic prescriptions (submitted by your computer directly to the pharmacy’s computer) compare to other prescription methods you use… in terms 
of patient safety?” No respondents indicated that electronic prescribing was “much worse” than other prescription methods in terms of patient safety.
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to 82%; Table 2). All security and confidentiality recom-
mendations were met by all vendors. The proportion of 
recommendations fully implemented for other domains 
displayed significant variation across software vendors.
Thirty percent of practices were solo practices, 30% were 
single specialty groups, and 19% were multispecialty groups. 
Nearly 40% of the practices were family medicine and 45% 
were internal medicine. Patient case mix included a mean 
of 43% (SD 26%) eligible for Medicare. Focus groups (n 
= 64 involving 276 participants) were composed mostly 
of prescribers (physicians, residents, nurse practitioners, and 
physician assistants; 64%), but medical assistants (12%), nurs-
es, office managers, pharmacists, and other office staff also 
participated in the focus groups. Eighty percent of survey 
respondents were physicians.
Quantitative Analysis
Of the 157 clinicians who completed the survey, 3 
reported not using e-prescribing and 9 did not answer 
the 2 questions of interest (4 clinicians using software 
from vendor D and 5 from vendor E). Overall, 35% 
of responders thought that e-prescribing was much 
better than other methods in terms of patient safety, 
and an additional 50% reported that e-prescribing 
was somewhat better (Figure 1). There was variation 
across software vendors; the proportion of clinicians 
who felt that e-prescribing was somewhat or much 
better than other methods of prescribing ranged from 
25% to more than 95%. Only 1 clinician reported a nega-
tive view of e-prescribing in relation to patient safety and 
quality of care. The proportion of clinicians who felt that 
e-prescribing was somewhat or much better than other 
methods of prescribing with respect to impact on the 
quality of care ranged from 25% to more than 95% de-
pending on software vendor; overall, 78% of clinicians 
surveyed felt that e-prescribing was much or somewhat 
better (Figure 2). 
Qualitative Analysis
Among users of e-prescribing software, a recurring 
theme was the importance of the medication list feature 
in improving patient safety. This feature was seen as a 
major advantage of e-prescribing. Participants reported 
using this feature to perform medication reconciliation.
Table 1. Focus Group Discussion Topics
• Experiences with electronic prescribing and e-prescribing software
• How did your practice change when e-prescribing software was implemented?
• What do patients think of electronic prescribing?
• Thoughts about medication history; thoughts about adherence?
• Thoughts about formulary and benefits features?
• Suggestions for improvement and other ideas
Figure 2. Perceptions of the Impact of e-Prescribing on Quality of Care, Overall and by e-Prescribing Technology Solutiona
20% 40% 60% 80%
Much better Somewhat better No change Somewhat worse
OVERALL (n = 145)
Vendor A (n = 28)
Vendor B (n = 30)
Vendor C (n = 4)
Vendor D (n = 26)
Vendor E (n = 43)
Vendor F (n = 14)
0% 100%
aThe participant survey asked “How do electronic prescriptions (submitted by your computer directly to the pharmacy’s computer) compare to other prescription methods you use…in terms 
of quality of care?” No respondents indicated that electronic prescribing was “much worse” than other prescription methods in terms of quality of care.
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One participant noted, “[A patient] was basically on ev-
erything he had before except for one…he didn’t remem-
ber, but I knew it from the list…it helps in reduction of 
errors. It helps in compliance because you see when they 
get it and when they don’t get it.” Another highly valued 
e-prescribing software feature was the ability to know 
what medications were prescribed by other providers. 
One participant claimed to “love the fact that you get 
the drugs that were prescribed in urgent care on the list 
because 9 of 10 patients when they come in for their 
follow-up—which urgent care always tells them to do—
they don’t remember which medicine they were put on.”
Although participants clearly articulated the patient 
safety value of having a medication list at the point of 
prescribing, the accuracy of the lists was questioned by 
some. Complaints about short-term medications (such 
as antibiotics) remaining indefinitely on the lists varied 
according to the specific e-prescribing software. Com-
plaints about not having complete information on all of 
the patients were common. Overall, participants greatly 
valued the ability to access medication lists remotely. Cli-
nicians commented on the need to prescribe after hours 
or away from their patients’ records. Remote access to 
the medication list was believed to improve patient safe-
ty. Some participants reported printing the medication list 
for their patients. According to one participant, “It really 
helps because at least they can take it home and call us 
back and clarify any differences between the two.”
Improved legibility was also perceived as a major ben-
efit of e-prescribing. However, participants felt that there 
will always be prescription or medication errors, and 
that the implementation of e-prescribing software would 
change rather than eliminate errors. A major type of er-
ror related to the dosing or scheduling of a medication. 
Other types of errors included accidentally prescribing 
the wrong drug or duplicate prescriptions. As one partici-
pant reported: “I’ve seen things where the staff handled 
a refill request and picked the wrong drug, a similar 
sounding name…I could have very easily prescribed the 
wrong drug or the wrong dosage.” Participants reported 
that errors occurred because of difficulty distinguishing 
between items in menus or because of errors in selecting 
options. Factors leading to selecting the wrong agents 
included the small size of handheld devices and columns 
too close together on the display. One participant noted 
that a prescription “somehow got switched…the viewing 
screen on that handheld is small, and it was a combi-
nation medicine. I couldn’t see all the components…he 
was getting one that contained aspirin instead of acet-
aminophen. He was somebody who shouldn’t be getting 
aspirin. And he had a serious complication from that.” 
Participants suggested ordering medications in ascend-
ing or descending order to prevent mistakes. Participants 
reported that medication errors stemming from e-pre-
scribing were typically caught by the pharmacists, error 
checking within the e-prescribing software, or patients. 
Table 3 summarizes key issues emerging from the focus 
groups.
DISCUSSION
This multistate, multivendor study confirms the value 
of e-prescribing for patient safety. Consistent with a recent 
study based on only 1 e-prescribing product in 1 state,12 
our study found that the majority of clinicians reported 
Table 2. Implementation of Best Practices Recommendations by e-Prescribing Software (Percentage of Recommendations 
Fully Implemented)
Software Vendor
Recommendation A B C D E F
Overall recommendations fully implemented 77 82 62 63 73 63
Patient identification and data access 100 100 100 50 75 100
Current	medications/medication	history	 87.5 87.5 75 50 62.5 75
Medication selection 64 93 57 50 64 64
Alerts and other messages to prescribers 83 83 42 67 75 50
Patient education 100 50 100 100 100 100
Data	transmission	and	storage	 71 86 43 86 86 57
Monitoring and renewals 40 60 40 40 20 40
Transparency and accountability 50 0 50 100 100 0
Prescriber-level feedback 100 50 100 50 100 50
Security and confidentiality 100 100 100 100 100 100
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at least some improvements in patient safety and quality 
of care with e-prescribing. Our study extends previous 
work by identifying the concerns of users regarding new 
forms of medication errors resulting from e-prescribing. 
Participants provided clear areas for improvement, as 
well as suggestions for preventing medication errors.
An estimated 7.6% of outpatient prescriptions have 
prescribing errors,13 and 4.1% of new e-prescriptions and 
2.1% of refill e-prescriptions require pharmacist inter-
vention.14 Our findings echo the work by Gandhi et al,13 
who argued that basic computerized prescribing systems 
may not be adequate to reduce errors. Our participants 
noted problems with dosages and directions, issues also 
brought up in interviews with pharmacy personnel.15 An 
audit of pharmacist medication interventions found that 
among e-prescriptions requiring intervention, 32% were 
due to missing information and 17.7% were due to dosing 
errors.14 While these data support the notion that more 
advanced systems with dose and frequency checking are 
needed to prevent potentially harmful errors, the extent 
to which such systems will be overridden remains un-
known.11 Another strategy to reduce errors in instructions 
and dosing is to develop and implement standards for 
terminology to code clinical drugs (RxNorm) and stan-
dards for medication instructions (structured and codified 
SIG). Indeed, a recent expert panel concluded that the 
lack of unambiguous drug identifiers in proposed stan-
dards suggests that more work is needed.16
Our study demonstrated that specific aspects of the 
software and hardware (eg, screen size, drop-down 
menus, order of choices) may contribute to the selec-
tion of wrong dose and drugs. Best practices should be 
identified by understanding the relationship of errors to 
characteristics of the software and hardware used for e-
prescribing, with methods such as those conceptualized 
by Bell et al,6 operationalized via consensus method with 
an expert panel,7 and evaluated in a field study.17 The 
human factors engineering approach to the development 
of tools such as e-prescribing may identify potentially 
dangerous usability flaws.18,19
Participants in our study believed the availability of a 
medication list as part of the e-prescribing software im-
proved patient safety. Our finding that participants used 
the medication list to reconcile medications with their 
patients confirms previous work indicating that use of 
e-prescribing systems in a standardized way to ensure 
accurate medication lists leads to significant patient safe-
ty gains.20 However, in another setting, when such data 
were provided, they were only accessed in 0.6% of clini-
cal encounters involving prescriptions.21 Our participants 
reported that medication lists were often incomplete or 
they did not have information on all of their patients. 
This is not surprising, because the extent of bidirectional 
flow of medication history data from comprehensive data 
sources is highly variable and is hampered by product 
limitations and external challenges related to implemen-
tation, including state variations in regulation of data and 
sharing of information across providers.22 Our data sug-
gest that clinicians believe that further patient safety gains 
could be realized if comprehensive, accurate medication 
lists were available at the point of prescribing.
Our study is not without limitations. While nonresponse 
bias is possible, we do not know whether participants 
were overly supportive of e-prescribing or overly negative. 
It is likely that this convenience sample captured partici-
pants who were representative of the most experienced 
e-prescribing users in primary care settings. Because they 
were not new users, it may be that these participants liked 
the software enough to continue using it. Second, the data 
included in this report were from a geographically diverse 
group of physician practices using 1 of 6 e-prescribing 
products. The variability in the e-prescribing software may 
give rise to interesting hypotheses to be explored in future 
research. Concerns may exist over the purposeful sam-
pling in this study. Yet for qualitative analysis, purposefully 
selecting an informative sample is a valid approach and 
Table 3. Summary of Key Advantages and Concerns About e-Prescribing That Emerged From Focus Groups
Patient Safety Advantages Patient Safety Concerns
Value in doing medication reconciliation at point of prescribing Validity and completeness of the information regarding medication
Knowing medications prescribed by other providers Accidentally prescribing duplicate medications
Remote access to patients’ medication lists so when clinician prescribes new  
medications off-site, it is done with knowledge of medication regimen
Drop-down	menu	issues	resulting	in	wrong	drug	or	dose	being	
prescribed
Ability to share list of medications with patients so they can use it at home 
to check against actual medicines
Small screen size on handheld devices leads to wrong drug or dose  
being prescribed
Reduces errors due to illegibility of handwriting Order of drop-down menus leads to wrong drug or dose being 
prescribed
e30	 	 The	American	Journal	of	Pharmacy	Benefits	 •	 March/April	2011	 	 www.ajpblive.com
n	 Lapane	•	Waring	•	Dubé	•	Schneider
can increase the quality and information of the data. Nev-
ertheless, even among e-prescribing users who are familiar 
with the technology, the findings did not appear to be 
overly optimistic regarding the impact of e-prescribing on 
patient safety in the ambulatory care setting.
CONCLUSIONS
Regardless of the e-prescribing software vendor, 
physicians representing diverse practice characteristics 
and locations overwhelmingly agreed that functionality 
included in many e-prescribing systems offers a patient 
safety advantage relative to other forms of prescribing. 
Given the conservative estimate of 530,000 preventable 
adverse drug events occurring in outpatient settings,23 
clinicians must have full knowledge of the current drug 
regimen to avoid preventable adverse drug events. While 
e-prescribing may be one method to improve patient 
safety related to medication errors, it is important to fur-
ther identify and promote best practices to minimize a 
new generation of medication errors resulting from the 
adoption of this technology.
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Appendix A. e-Prescribing Previsit Web Survey: CLINICIAN SURVEY
This survey is part of a research project funded by the US Department of Health and Human Services (HHS) and supported by your 
employer. The purpose of the survey is to assess your opinions about electronic prescribing and how it has influenced how you do your job. 
The survey should take approximately 15 minutes to complete, and your responses will be kept confidential.
We greatly appreciate your cooperation. If you have any questions regarding this study, please contact me directly at [e-mail address] 
or call [phone number].
Thank you for your help.
 1.   What is your first name: ____________________________________________________________________________  
     
	 2.	 	In	what	state	is	your	group/practice	located:		 ________________________________________________________
	 3.	 	What	is	the	name	of	your	group/practice:	 ________________________________________________________
	 4.	 	Which	of	the	following	e-prescribing	software	does	your	group/practice	use?
	 	 	 a.	OnCallData	 	 d.	PocketScript
   b. eMPOWERx  e. eMaxx
   c. TouchWorks   f. Rcopia
 5.  What is your gender?
   a. Male   b. Female
 6.  What is the highest level of education completed?
	 	 	 a.	Did	not	complete	high	school	 e.	Associate	degree
	 	 	 b.	High	school	diploma	or	GED	 f.	Bachelor’s	degree
	 	 	 c.	Vocational/trade	school	 g.	Postgraduate	degree
   d. Some college
 7.  Are you a clinician that prescribes medicines for patients? 
   a. YES    b. NO 
 8.  What is your job? 
   a. Physician   d. Physician Assistant
   b. Resident   e. Pharmacist
   c. Nurse Practitioner  f. Other:  _________________________________________________________
 How many minutes per day do you now (or did you prior to implementation of electronic prescribing software) perform the following:
 9.  Resolve prescription problems with the pharmacy? Please enter average time. No ranges.
	 	 	____	total	minutes/day	before	e-prescribing	 ____	total	minutes/day	after e-prescribing
	 10.	 	Respond	to	and	process	pharmacy	refill/renewal	requests?	Please	enter	average	time.	No	ranges.
	 	 	____	total	minutes/day	before	e-prescribing	 ____	total	minutes/day	after e-prescribing
 11.  Obtain prior approval for drugs as specified in patients’ prescription plans? Please enter average time. No ranges.
	 	 	____	total	minutes/day	before	e-prescribing	 ____	total	minutes/day	after e-prescribing
 12.  Some e-prescribing technologies have computer-generated drug alerts. How often do you override computer-generated drug alerts?
                    Never                Sometimes          Most of the Time                  Always
   a. Allergy alerts   1  2  3  4
	 	 	 b.		Drug-to-drug	interactions	 	 1	 	 2	 	 3	 	 4
	 	 	 c.	Dose	checks	 	 	 1	 	 2	 	 3	 	 4
	 	 	 d.	Drug-to-food	interactions	 	 1	 	 2	 	 3	 	 4
	 	 	 e.	Drug-to-alcohol	interactions	 1	 	 2	 	 3	 	 4
           f. Health state interactions  1  2  3  4
 13.  Are the alerts in the prescriber software system adequate? Please describe:
   _______________________________________________________________________________________________  
   _______________________________________________________________________________________________  
   _________________________________________________________________
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 14.  Please rate these different methods of prescribing from your perspective:
                                                              Very               Moderately          Moderately              Very  Do Not 
                                                                          Inefficient            Inefficient            Efficient              Efficient Use
   a. Handwritten 1 2 3 4 5
   b. Faxed (fax machine)  1 2 3 4 5
   c. Faxed (computer fax) 1 2 3 4 5
   d. Sent electronically to the  1 2 3 4 5 
          pharmacy’s computer    
   e. Phone-in 1 2 3 4 5
	 									f.	Computer	generated/printed	out	 1	 2	 3	 4	 5
	 15.	 	Do	 you	 use	 any	 aspect	 of	 the	 e-prescribing	 software	 (such	 as	 OnCallData,	 eMPOWERx,	 TouchWorks,	 PocketScript,	 eMaxx,	 
   or Rcopia)?
   a. NO (skip to question 17)  b. YES (continue with question 16)
 16.  In a typical week, how often do you use these features of the e-prescribing software?
                                                                                         Most of                               Not 
                                      Never      Sometimes       the Time        Always         Available
	 	 	 a.	Entering/revising	patient	information	 	 1	 2	 3	 4	 5
   b. Entering new prescriptions   1 2 3 4 5 
	 	 	 c.	Approving	and/or	submitting	new	 	 	 1	 2	 3	 4	 5 
         prescriptions 
	 	 	 d.	Entering	information	for	refills/renewals	 	 1	 2	 3	 4	 5
	 	 	 e.	Approving	and/or	submitting	refills/renewals	 	 1	 2	 3	 4	 5
   f. Reviewing patients’ medication history  1 2 3 4 5
   g. Reviewing drug reference information  1 2 3 4 5
   h. Reviewing formulary information   1 2 3 4 5
 `  i. Entering over-the-counters, supplements  1 2 3 4 5
   j. Entering samples given to patients   1 2 3 4 5
	 	 	 k.	Checking	and/or	updating	medication	list		 	 1	 2	 3	 4	 5 
          with patient 
   l. Checking lab values in relation to medication use 1 2 3 4 5 
   m. Printing patient drug info sheets for patients  1 2 3 4 5
   n. Accessing patient data from other locations  1 2 3 4 5
   o. Ordering prescriptions from home, hospital,   1 2 3 4 5 
          or other locations 
   p. Building a medication favorite list   1 2 3 4 5
	 	 	 q.	Entering	medications	administered	in	MD	office	 1	 2	 3	 4	 5 
             (ie, immunizations)  
   r. Printing reports for the patient’s chart  1 2 3 4 5
   s. Printing other reports    1 2 3 4 5
 17.  The next question addresses how you believe e-prescribing has impacted your workplace. From your perspective, how does using   
            the e-prescribing software compare to previous methods in the following areas?
                       Much        Somewhat         No           Somewhat        Much 
                        Worse           Worse          Change          Better           Better
   a. Patient safety    1 2 3 4 5
   b. Quality of care    1 2 3 4 5
   c. Efficiency of care (eg, increased work flow   1 2 3 4 5  
                 and productivity)  
   d. Communications with the patient   1 2 3 4 5
   e. Communications with the pharmacy  1 2 3 4 5
           f. Overall relationship with the patient  1 2 3 4 5
          g. Overall relationship with the pharmacy  1 2 3 4 5
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 18.  The next few questions address issues of communication with respect to medication use.
                        Most of 
                         Never        Sometimes     the Time        Always
   a. How often do you have discussions with other other prescribers 1 2 3 4 
           regarding coordination of medications?   
   b. How often do you have discussions with patients regarding lack 1 2 3 4 
              of adherence?    
   c. How often do you have discussions with patients regarding     1 2 3 4 
              potential adverse drug effects?    
   d. How often do you discuss the costs of medications with   1 2 3 4 
          your patients?     
   e. How often would your patients tell you if they did not want  1 2 3 4 
          a prescription you ordered for them?     
   f. How often would your patients tell you if they did not plan  1 2 3 4 
          to purchase a medication you were ordering for them?   
 19.  Based on your own experience, please rate your overall satisfaction with these different methods of prescribing:
                      Very          Somewhat      Somewhat        Very           Do Not 
                  Unsatisfied     Unsatisfied     Satisfied      Satisfied          Use
   a. Handwritten    1 2 3 4 5
   b. Faxed (fax machine)    1 2 3 4 5 
   c. Faxed (via computer)     1 2 3 4 5
   d. Sent electronically to the pharmacy’s computer  1 2 3 4 5
   e. Phone-in     1 2 3 4 5
          f. Printed from computer    1 2 3 4 5
 20.   OVERALL—how would you say that the use of the e-prescribing software has affected your job compared to previous methods?
   a. Made my job much more difficult
   b. Made my job a little more difficult
   c. No change
   d. Made my job a little easier
   e. Made my job a lot easier
 21.   Please enter what you feel is the biggest positive impact e-prescribing software has had on your work: 
   ___________________________________________________________________________________________  
   ___________________________________________________________________________________________  
   ______________________________________________
 22.  Please enter what you feel is the biggest negative impact e-prescribing software has had on your work:
   ___________________________________________________________________________________________  
   ___________________________________________________________________________________________  
   ____________________________________________
THANK YOU!
e34	 	 The	American	Journal	of	Pharmacy	Benefits	 •	 March/April	2011	 	 www.ajpblive.com
n	 Lapane	•	Waring	•	Dubé	•	Schneider
Appendix B. e-Prescribing Code Structure
Benefits Problems Suggestions















































































Patient drug info sheets




































Auth indicates authorization; Hx, history; IT, information technology; NP, nurse practitioner; OTC, over the counter; PA, physician assistant; Pharm, pharmacy; Psych, psychologist; Pt, patient; Rx, 
prescription.
